Injectable depot formulation comprising cyrstals of iloperidone

Details for Australian Patent Application No. 2003281154 (hide)

Owner Novartis AG

Inventors Glausch, Alexandra; Wieckhusen, Dierk; Ahlheim, Markus

Agent Davies Collison Cave

Pub. Number AU-B-2003281154

PCT Number PCT/EP2003/0076

PCT Pub. Number WO2004/006886

Priority 0216416.8 15.07.02 GB

Filing date 14 July 2003

Wipo publication date 2 February 2004

Acceptance publication date 12 October 2006

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/454 (2006.01)

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

Event Publications

4 March 2004 Complete Application Filed

  Priority application(s): 0216416.8 15.07.02 GB

18 March 2004 Application Open to Public Inspection

  Published as AU-B-2003281154

12 October 2006 Application Accepted

  Published as AU-B-2003281154

15 February 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003281155-METHOD OF SEPARATING R(-)- AND S(+)-5-(2-((2-(2-ETHOXYPHENOXY)E THYL)AMINO)PROPYL-2-METHOXYB ENZENE-SULPHONAMIDE

2003281153-NOVEL SLOW RELEASE INSECT REPELLENT COMPOUNDS AND METHOD FOR DELIVERING THE ACTIVE INGREDIENT